The famhp is the competent authority responsible for the quality, safety and efficacy of medicines and health products. We work together with health professionals and other competent authorities at the national and international level to ensure the population the optimal use of the medicines and health products they need.
The company provides strong expertise and experience in the design and implementation of Early Clinical Plans, Translational Medicine Scientific Strategy, and in the execution of clinical Phase I and Phase II studies. The critical information collected during these studies, in particular, determines the probability of success for the late stage clinical development.
As a distributor and manufacturer of scientific instruments for laboratories and lab furniture, Analis is primarily oriented towards research activities, life science & biotechnology, medical in vitro diagnosis and industrial quality control. Providing a High Level of Service to your lab, that's our priority.
Aquilon Pharma focuses on the early steps of drug development. It identifies, evaluates and licenses in promising academic projects in the pulmonary field. It then uses its translational expertise to consolidate the pharmaceutical, pre-clinical, toxicological, clinical and intellectual property packages, so as to increase the value and license out the developed and matured product(s).
Artialis offers biomarker-based solutions to address unmet needs for your product development in musculoskeletal disorders. From preclinical studies to postmarketing clinical trials, Artialis provides scientific expertise, R&D support services, and tools for the evaluation of clinical, structural, and biological impact of a compound on musculoskeletal health.